Business
Duke University Health Center -- One of America's Top Heart-care Institutions and Innovators -- Purchases Ventripoint's AI Heart-scan Technology
(TheNewswire) Toronto, Ontario – TheNewswire - May 1, 2024 - Ventripoint...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Duke University Health Center -- One of America's Top Heart-care Institutions and Innovators -- Purchases Ventripoint's AI Heart-scan Technology\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Toronto, Ontario –\n \n \n TheNewswire -\n \n \n May 1, 2024\n \n \n -\nVentripoint Diagnostics Ltd.\n \n \n (\"\n \n \n Ventripoint\n \n \n \" or\nthe \"\n \n \n Company\n \n \n \"), (TSXV:VPT\n \n \n )\n \n \n ;\n \n \n (\n \n \n OTC:VPTDF)\n \n \n is pleased to announce that Duke University\nHealth Center has purchased its second VMS+ unit from Ventripoint ,\nwhich processes ultrasound images of the heart to generate MRI-quality\nmeasurements in minutes.\n \n \n \n \n Duke Health Center Arringdon, part of the Duke\nUniversity Health System located in Durham, North Carolina. Duke\nHealth, is affiliated with Duke University and is a world-class\nacademic and health care system.\n \n \n \n \n “Tools that allow us to reduce the cost and time\nneeded for reliable diagnostics can potentially save the lives of\ninfants, children and adults with heart conditions,” said Richard\nKrasuski, M.D., director of Duke’s Adult Congenital Heart\nProgram.\n \n \n \n \n Duke Children’s Hospital has been using\nVentripoint’s VMS+ system for two years, focusing primarily on\nsingle ventricle paediatric patients. Now, the VMS+ will be\nimplemented at Duke Cardiology Arringdon and will be used in real-time\nadult patient heart scans and help Duke further its study of\nVentripoint’s potential.\n \n \n \n \n “We are very excited to work with Duke Cardiology\nArringdon on our latest VMS+ system for their cardiac clinic,” said\nVentripoint Interim CEO, Hugh MacNaught. “We have had great success\nworking with Duke for their children’s health clinic, and we are\nsure that the Adult Congenital Heart Disease program will also\nexperience great results.”\n \n \n \n \n The VMS+ provides diagnostic and treatment procedures,\nresulting in scans of all four chambers of the heart at a fraction of\nthe cost and time needed for cardiac MRIs. The ease of use of\nVentripoint’s A.I. technology also means that patients can receive\nnumerous heart scans, to assist caregivers in treatment and pa...